Anna Richo

Insider Reports History

Identity Who this page is about. 1 identity field
Location
Chicago, IL
SEC source record Original filing metadata and source links. 1 source field
Owner filing signature
Robert Maynes for Anna Richo
Source evidence Original filing metadata and source links. 1 source field
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Anna Richo

Form 4 holding Director

EXELON CORP

Security class
Common stock- deferred stock units
Shares / value
11,337
Estimated value
$455,019
Report date
31 Mar 2026
Price
$43.87
Ownership
By Exelon Corp. Directors Deferred Stock Unit Plan
Form 4 holding Director

EXELON CORP

Security class
Deferred phantom share equivalents
Shares / value
7,930
Estimated value
$385,318
Report date
28 Apr 2026
Price
$48.59
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,930
Form 4 holding Director

EXELON CORP

Security class
2026 Directors Restricted Stock Units
Shares / value
3,720
Estimated value
Report date
28 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Adamas Pharmaceuticals Inc

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
24 Nov 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Anna Richo

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .